258 related articles for article (PubMed ID: 22351710)
21. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda N; Yorita K; Nagasaki M; Harada Y; Ohe C; Jeruc J; Raspollini MR; Michal M; Hes O; Amin MB
Pol J Pathol; 2016 Mar; 67(1):3-7. PubMed ID: 27179267
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.
Casey RT; Warren AY; Martin JE; Challis BG; Rattenberry E; Whitworth J; Andrews KA; Roberts T; Clark GR; West H; Smith PS; Docquier FM; Rodger F; Murray V; Simpson HL; Wallis Y; Giger O; Tran M; Tomkins S; Stewart GD; Park SM; Woodward ER; Maher ER
J Clin Endocrinol Metab; 2017 Nov; 102(11):4013-4022. PubMed ID: 28973655
[TBL] [Abstract][Full Text] [Related]
23. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.
Gimm O; Armanios M; Dziema H; Neumann HP; Eng C
Cancer Res; 2000 Dec; 60(24):6822-5. PubMed ID: 11156372
[TBL] [Abstract][Full Text] [Related]
24. Germline mutations in PTEN and SDHC in a woman with epithelial thyroid cancer and carotid paraganglioma.
Zbuk KM; Patocs A; Shealy A; Sylvester H; Miesfeldt S; Eng C
Nat Clin Pract Oncol; 2007 Oct; 4(10):608-12. PubMed ID: 17898811
[TBL] [Abstract][Full Text] [Related]
25. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas.
Mhatre AN; Li Y; Feng L; Gasperin A; Lalwani AK
Clin Genet; 2004 Nov; 66(5):461-6. PubMed ID: 15479192
[TBL] [Abstract][Full Text] [Related]
26. Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas.
Hoekstra AS; Hensen EF; Jordanova ES; Korpershoek E; van der Horst-Schrivers AN; Cornelisse C; Corssmit EP; Hes FJ; Jansen JC; Kunst HP; Timmers HJ; Bateman A; Eccles D; Bovée JV; Devilee P; Bayley JP
Oncotarget; 2017 Feb; 8(9):14525-14536. PubMed ID: 28099933
[TBL] [Abstract][Full Text] [Related]
27. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.
Pasini B; McWhinney SR; Bei T; Matyakhina L; Stergiopoulos S; Muchow M; Boikos SA; Ferrando B; Pacak K; Assie G; Baudin E; Chompret A; Ellison JW; Briere JJ; Rustin P; Gimenez-Roqueplo AP; Eng C; Carney JA; Stratakis CA
Eur J Hum Genet; 2008 Jan; 16(1):79-88. PubMed ID: 17667967
[TBL] [Abstract][Full Text] [Related]
28. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas.
Korpershoek E; Favier J; Gaal J; Burnichon N; van Gessel B; Oudijk L; Badoual C; Gadessaud N; Venisse A; Bayley JP; van Dooren MF; de Herder WW; Tissier F; Plouin PF; van Nederveen FH; Dinjens WN; Gimenez-Roqueplo AP; de Krijger RR
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1472-6. PubMed ID: 21752896
[TBL] [Abstract][Full Text] [Related]
29. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
Papathomas TG; Gaal J; Corssmit EP; Oudijk L; Korpershoek E; Heimdal K; Bayley JP; Morreau H; van Dooren M; Papaspyrou K; Schreiner T; Hansen T; Andresen PA; Restuccia DF; van Kessel I; van Leenders GJ; Kros JM; Looijenga LH; Hofland LJ; Mann W; van Nederveen FH; Mete O; Asa SL; de Krijger RR; Dinjens WN
Eur J Endocrinol; 2014 Jan; 170(1):1-12. PubMed ID: 24096523
[TBL] [Abstract][Full Text] [Related]
30. [Heredity in renal and prostatic neoplasia].
Prayer Galetti T; D'Arrigo L; De Zorzi L; Patarnello T
Arch Ital Urol Androl; 1997 Sep; 69(4):241-6. PubMed ID: 9417296
[TBL] [Abstract][Full Text] [Related]
31. SDHC phaeochromocytoma and paraganglioma: A UK-wide case series.
Williams ST; Chatzikyriakou P; Carroll PV; McGowan BM; Velusamy A; White G; Obholzer R; Akker S; Tufton N; Casey RT; Maher ER; Park SM; Porteous M; Dyer R; Tan T; Wernig F; Brady AF; Kosicka-Slawinska M; Whitelaw BC; Dorkins H; Lalloo F; Brennan P; Carlow J; Martin R; Mitchell AL; Harrison R; Hawkes L; Newell-Price J; Kelsall A; Igbokwe R; Adlard J; Schirwani S; Davidson R; Morrison PJ; Chung TT; Bowles C; Izatt L
Clin Endocrinol (Oxf); 2022 Apr; 96(4):499-512. PubMed ID: 34558728
[TBL] [Abstract][Full Text] [Related]
32. Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma.
Burnichon N; Buffet A; Parfait B; Letouzé E; Laurendeau I; Loriot C; Pasmant E; Abermil N; Valeyrie-Allanore L; Bertherat J; Amar L; Vidaud D; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2012 Dec; 21(26):5397-405. PubMed ID: 22962301
[TBL] [Abstract][Full Text] [Related]
33. Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations.
Ercolino T; Becherini L; Valeri A; Maiello M; Gaglianò MS; Parenti G; Ramazzotti M; Piscitelli E; Simi L; Pinzani P; Nesi G; Degl'Innocenti D; Console N; Bergamini C; Mannelli M
Clin Endocrinol (Oxf); 2008 May; 68(5):762-8. PubMed ID: 18031321
[TBL] [Abstract][Full Text] [Related]
34. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
Bertherat J; Gimenez-Roqueplo AP
Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332
[TBL] [Abstract][Full Text] [Related]
35. SDHA is a tumor suppressor gene causing paraganglioma.
Burnichon N; Brière JJ; Libé R; Vescovo L; Rivière J; Tissier F; Jouanno E; Jeunemaitre X; Bénit P; Tzagoloff A; Rustin P; Bertherat J; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2010 Aug; 19(15):3011-20. PubMed ID: 20484225
[TBL] [Abstract][Full Text] [Related]
36. The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).
Else T; Marvin ML; Everett JN; Gruber SB; Arts HA; Stoffel EM; Auchus RJ; Raymond VM
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1482-6. PubMed ID: 24758179
[TBL] [Abstract][Full Text] [Related]
37. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
38. Screening of mutations in genes that predispose to hereditary paragangliomas and pheochromocytomas.
Lefebvre S; Borson-Chazot F; Boutry-Kryza N; Wion N; Schillo F; Peix JL; Brunaud L; Finat A; Calender A; Giraud S
Horm Metab Res; 2012 May; 44(5):334-8. PubMed ID: 22517554
[TBL] [Abstract][Full Text] [Related]
39. Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4.
Gill AJ; Pachter NS; Clarkson A; Tucker KM; Winship IM; Benn DE; Robinson BG; Clifton-Bligh RJ
N Engl J Med; 2011 Mar; 364(9):885-6. PubMed ID: 21366490
[No Abstract] [Full Text] [Related]
40. SDHC mutation in an elderly patient without familial antecedents.
López-Jiménez E; de Campos JM; Kusak EM; Landa I; Leskelä S; Montero-Conde C; Leandro-García LJ; Vallejo LA; Madrigal B; Rodríguez-Antona C; Robledo M; Cascón A
Clin Endocrinol (Oxf); 2008 Dec; 69(6):906-10. PubMed ID: 18681855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
